7,484 Shares in CVS Health Corporation $CVS Purchased by Hennion & Walsh Asset Management Inc.

Hennion & Walsh Asset Management Inc. purchased a new stake in shares of CVS Health Corporation (NYSE:CVS) in the third quarter, Holdings Channel.com reports. The firm purchased 7,484 shares of the pharmacy operator’s stock, valued at approximately $564,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Cantor Fitzgerald Investment Advisors L.P. lifted its holdings in CVS Health by 1.6% during the second quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock worth $28,264,000 after acquiring an additional 6,615 shares during the period. Alpha Omega Wealth Management LLC raised its stake in shares of CVS Health by 12.3% during the 3rd quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock worth $11,301,000 after purchasing an additional 16,418 shares during the period. Aaron Wealth Advisors LLC boosted its holdings in shares of CVS Health by 177.4% in the 3rd quarter. Aaron Wealth Advisors LLC now owns 34,259 shares of the pharmacy operator’s stock worth $2,583,000 after buying an additional 21,911 shares during the last quarter. Red Mountain Financial LLC purchased a new stake in CVS Health during the second quarter worth about $293,000. Finally, Osaic Holdings Inc. raised its position in CVS Health by 18.4% in the second quarter. Osaic Holdings Inc. now owns 229,903 shares of the pharmacy operator’s stock worth $15,828,000 after acquiring an additional 35,809 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Price Performance

CVS stock opened at $80.29 on Friday. The firm has a 50 day moving average of $78.70 and a 200-day moving average of $73.88. The firm has a market capitalization of $101.92 billion, a P/E ratio of 211.29, a price-to-earnings-growth ratio of 0.74 and a beta of 0.48. CVS Health Corporation has a 12 month low of $46.34 and a 12 month high of $85.15. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.24. The business had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period in the prior year, the company posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, February 2nd. Investors of record on Thursday, January 22nd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date is Thursday, January 22nd. CVS Health’s payout ratio is presently 700.00%.

Analysts Set New Price Targets

CVS has been the subject of several research analyst reports. Evercore ISI raised their price target on shares of CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Mizuho increased their price target on CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. Robert W. Baird upped their price objective on shares of CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday, December 10th. Truist Financial set a $100.00 target price on shares of CVS Health in a research note on Wednesday, December 10th. Finally, TD Cowen upped their price target on shares of CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, December 10th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $94.86.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.